Search results for "Liver function"

showing 10 items of 176 documents

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

2015

According to the guidelines of the European Association for the Study of the Liver (EASL), patients affected from hepatocellular carcinoma (HCC) can be classified according to the Barcelona Clinic Liver Cancer (BCLC) staging system. This classification system divides HCC patients in five stages (0, A, B, C and D) on the basis of a number of prognostic and treatment- related variables such as tumor status and liver function. A specific treat ment approach is then proposed for each of the above-mentioned stages. Transarterial chemoembolization (TACE) is recommended as first-line therapy in the treatment of patients with intermediate-stage (BCLC-B class) HCC [1]. The efficacy of this procedure…

SorafenibOncologyNiacinamideCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularCombination therapyHCC; TACE; combination therapy; intermediate stage; sorafenibAntineoplastic Agentscombination therapyInternal medicineMedicineHumansStage (cooking)Chemoembolization TherapeuticHCCProtein Kinase InhibitorsTACEintermediate stagePerformance statusbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral Medicinemedicine.diseaseCombined Modality Therapydigestive system diseasesPortal vein thrombosisSurgeryOncologyHepatocellular carcinomasorafenibLiver functionbusinessLiver cancermedicine.drug
researchProduct

Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients

2013

Background & Aims The BCLC-staging system is used to facilitate treatment decisions in patients with hepatocellular carcinoma (HCC). Owing to the observed clinical heterogeneity of the intermediate stage BCLC-B, a subclassification was proposed taking Child–Pugh score and extended criteria for transplantation into account. Analysis of the prognostic significance of a proposed subclassification of the BCLC-B score in a European cohort of HCC patients. Methods Eight hundred and eighty four consecutive HCC patients were retrospectively analysed. Patients with stage BCLC-B were grouped according to the proposed subclassification. Baseline patient and tumour characteristics, therapy and overall …

SorafenibOncologymedicine.medical_specialtyCarcinoma HepatocellularStatistics NonparametricInternal medicineHumansMedicineStage (cooking)Survival analysisNeoplasm StagingRetrospective StudiesHepatologybusiness.industryProportional hazards modelLiver NeoplasmsPrognosismedicine.diseaseSurvival AnalysisSurgeryEuropeTransplantationHepatocellular carcinomaCohortRegression AnalysisLiver functionbusinessmedicine.drugLiver International
researchProduct

Prolonged anaesthesia with isoflurane and halothane. Effects on hepatic function.

2007

Hepatic function was assessed pre-operatively and on the first and sixth postoperative days in 40 healthy patients who underwent prolonged maxillofacial surgery with isoflurane or halothane anaesthesia. No major changes were observed in hepatic enzymes or bilirubin. One-stage prothrombin time and Factor VII concentrations decreased on the first postoperative day and this change was more pronounced in the halothane group. The results support the use of isoflurane rather than halothane for prolonged anaesthesia in respect of the synthesising function of the liver.

Time FactorsBilirubinHepatic functionchemistry.chemical_compoundmedicineHumansProthrombin timebiologymedicine.diagnostic_testFactor VIIIsofluranebusiness.industryFactor VFactor VBilirubinFactor VIIAnesthesiology and Pain MedicinechemistryIsofluraneLiverAnesthesiabiology.proteinProthrombin TimeLiver functionHalothanebusinessAnesthesia InhalationHalothanemedicine.drugAnaesthesia
researchProduct

Voriconazole and the liver.

2015

Voriconazole is an azole useful for the prophylaxis and the treatment of aspergillosis and other fungal infections in immunosuppressed subjects, as those found in aplasia after aggressive polychemotherapy treatments, after hematopoietic stem cell, liver or lung transplantation. Its administration in therapeutic doses lead to extremely varied serum levels from patient to patient and even to the same patient. The explanations are varied: nonlinear pharmacokinetics, certain patient-related factors, including genetic polymorphisms in the cytochrome P450 2C19 gene, the kidney and liver function, simultaneous administration with other drugs metabolised by the same cytochrome. It is recommended to…

Voriconazolemedicine.medical_specialtyHepatologymedicine.diagnostic_testbusiness.industryCYP2C19Pharmacologymedicine.diseaseAspergillosisGastroenterologyEditorialCholestasisTherapeutic drug monitoringInternal medicineToxicitymedicineLiver functionbusinessAdverse effectmedicine.drugWorld journal of hepatology
researchProduct

Abnormal liver function in brucellosis

2008

We assessed the prevalence of impaired liver function in 47 patients suffering from brucellosis consecutively admitted to our department over the last five years. Parameters of liver function and ultrasound of the upper abdomen were performed at entry and at the end of treatment. On admission, mean transaminase values were elevated and significantly higher than at recovery (p 0.001): 38 percent and 53 percent of patients had elevated baseline values of GOT and GPT vs 13 and 19% at the end of treatment, respectively. Mean serum values of alkaline phosphatase (AP) were within normal limits on admission, although in 12 of them serum values were elevated. The same proportion was seen for gamma-…

brucellosis infection disease liver function
researchProduct

Asialofetuin Liposomes for Receptor-Mediated Gene Transfer into Hepatic Cells

2003

Publisher Summary The liver is an excellent organ for gene transfer in treating a wide variety of diseases that affect liver function. It is an ideal organ for a high amount of expression of therapeutic genes and efficient systemic distribution of the resulting therapeutic proteins secreted into the bloodstream. For strategies of liver-destined gene therapy, the liver sinusoid endothelium contains pores with a mean diameter of 100 nm, which allow small vectors to leave the blood circulation and reach the hepatocytes. The preparation of asialofetuin–liposomes targeted to hepatocytes can be made by covalent coupling of asialofetuin glycoprotein (ASF) onto the liposome surface, by the use of h…

chemistry.chemical_classificationLiver sinusoidLiposomeReceptor-mediated endocytosisBiologymedicine.anatomical_structurechemistryBiochemistryBiophysicsmedicineCationic LipopeptidesCationic liposomeLiver functionGlycoproteinNuclear localization sequence
researchProduct

Biochemical adaptations in middle-distance runners: an assessment of blood and anthropometric parameters

2014

In order to understand the mechanism underlying the physiological adaptation of purely aerobic workout, we investigated the effect of 2 months of training on nine males (17-22 year-old) middle distance running agonistic athletes. Blood sample was collected in the morning to analyze: hematological parameters, lipid profile, liver function enzymes [glutamate oxaloacetate transaminase, glutamate pyruvate transaminase, gamma-glutamyl transferase (γ-GT)] and skeletal and myocardial markers of muscle damage [creatin kinase (CK) and creatin kinase MB (CK-MB)]. Endurance training, as it implies high oxygen consumption, should increase reactive oxygen species, but it has been shown that exercise lea…

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentPlant ScienceOxidative phosphorylationBiologymedicine.disease_causeSettore BIO/09 - FisiologiaGeneral Biochemistry Genetics and Molecular BiologyEndurance trainingInternal medicineSettore BIO/10 - BiochimicamedicineAerobic exerciselcsh:QH301-705.5MorningSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' Sportivemedicine.diagnostic_testBiochemistry (medical)Endocrinologylcsh:Biology (General)BiochemistryLiver functionmiddle-distance runners oxidative stress CK-MB biochemical parameters body weightLipid profileSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieOxidative stress
researchProduct

Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.

2021

BACKGROUND & AIMS Hepatocellular carcinoma (HCC) is a common complication of chronic liver disease with diverse underlying aetiologies. REACH/REACH-2 were global phase III studies investigating ramucirumab in advanced HCC (aHCC) following sorafenib treatment. We performed an exploratory analysis of outcomes by liver disease aetiology and baseline serum viral load. METHODS Meta-analysis was conducted in patients with aHCC and alpha-fetoprotein (AFP) ≥400 ng/mL (N = 542) from REACH/REACH-2 trials. Individual patient-level data were pooled with results reported by aetiology subgroup (hepatitis B [HBV] or C [HCV] and Other). Pre-treatment serum HBV DNA and HCV RNA were quantified using Roche CO…

medicine.medical_specialtyCarcinoma Hepatocellular610 Medizin610 Medicine & healthChronic liver diseaseAntibodies Monoclonal HumanizedGastroenterologyRamucirumab03 medical and health sciencesLiver disease0302 clinical medicine610 Medical sciencesInternal medicineMedicineHumans030304 developmental biology0303 health sciencesHepatologybusiness.industryLiver NeoplasmsHepatitis CHepatitis Bmedicine.diseasedigestive system diseases3. Good healthClinical Trials Phase III as Topic030220 oncology & carcinogenesisHepatocellular carcinomaLiver functionbusinessViral load
researchProduct

Imaging-Based Preoperative Planning

2017

Liver resection in the treatment of colorectal liver metastases, as for any other primary or secondary liver tumor, needs to be oncologically effective and surgically safe. Both goals need equal consideration, and imaging-based preoperative planning is paramount for achieving each of them. Preoperative imaging should ideally identify all metastatic lesions in the liver, as well as extrahepatic disease. Furthermore, it should provide an anatomical roadmap with the exact localization of each lesion within the segmental hepatic anatomy, and its proximity to adjacent vasculo-biliary structures, to allow for proper resection leaving the patient with a sufficiently functioning liver remnant. This…

medicine.medical_specialtyChemotherapyLiver tumorMetastatic lesionsPreoperative planningmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentmedicine.diseaseResectionLesionmedicineRadiologymedicine.symptombusinessLiver function testsPreoperative imaging
researchProduct

Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: The interim analysis of the ANSWER study

2015

s / Digestive and Liver Disease 47S (2015) e1–e18 e7 (months; 95% CI): CPT 0 62 (52.9–71.1), A 44 (41.6–46.4), B 22 (19.7–24.3), C 9 (6.6–11.3), p<0.0001. Comparisons between survivals of CTP 0 vs A, B and C were also statistically different (p<0.0001 in all associations). The prognosis of patients in the intermediateBCLCstagealsodifferedaccording to the liver function (0 vs A vs B, p<0.0001). Conclusions: The newly proposed CTP class 0 identifies a different subgroup of patientswith a better prognosis, alsowhen applied in a European cohort, where HCV aetiology is predominant. This new approach impacts not only on outcome prediction but also, potentially, on treatment allocation, better str…

medicine.medical_specialtyCirrhosisHepatologybusiness.industryGastroenterologymedicine.diseaseInterim analysisGastroenterologyLiver diseaseInternal medicineCohortAscitesmedicineEtiologyLiver functionStage (cooking)medicine.symptombusinessDigestive and Liver Disease
researchProduct